Gallbladder carcinoma is the 5th most common gastrointestinal tract cancers and is an aggressive malignancy with varied presentation. The predominant sites of mestatasis being liver and regional lymph nodes. Skeletal metastasis in gallbladder carcinoma is very rare and only 15 cases have been reported in English literature so far. In this manuscript, we describe our experience of two cases of skeletal metastasis in carcinoma gallbladder.
Introduction
Gallbladder cancer is the most common of all the biliary tract cancers and is fifth most common of the gastrointestinal tract. Gallbladder cancer preferentially metastasizes to regional lymph nodes and liver parenchyma. Bone metastasis from gallbladder carcinoma are rare presentation. In a study by Sameer G et al. [1] 2.5% patients have cytologically proven skeletal metastasis. However, one autopsy series has reported about 10% incidence, which may indicate that the carcinoma gall bladder does metastasize to bone, perhaps in advanced stages [2] . To date there have only been a few case reports of bone metastasis in carcinoma gall bladder at the time of presentation. We report here two cases of gallbladder carcinoma with bony metastases.
Case Report -1
A normotensive and nondiabetic male patient of age 30 year from Patna (India) presented to Mahavir Cancer Sansthan on 8 th January 2018 with complain of right hypochondrial pain and severe back pain for last 3 months. There is past history of lap cholecystectomy and appendicectomy on 26 th September 2017 outside for cholecystitis and appendicitis. Histopathology report was adenocarcinoma Grade II, scirrhous type with invasion into the serosa. He received one cycle of Gem + Cis based chemotherapy regimen outside (Last Date C1D8 -25 -12-2017). PET CT ( Attenuation correction images also show cortical erosion in middle 3 rd of left femoral shaft with increased tracer uptake and a gallbladder lesion. Ultrasound whole abdomen (29 th March 2018) showed 27.9 x 26.5 mm size heterogeneous lesion in gallbladder fundal region with ill-defined gallbladder wall. Few periampullary nodal masses and mild ascites was also present. Ultrasound guided FNA from GB mass confirmed adenocarcinoma. Palliative radiotherapy (Fig -4) to right shoulder and right elbow by Co-60 to a dose of 30 Gy/10# given uneventfully. She was started on Gem + Cis + Zolendronic Acid based chemotherapy regimen, but after C3D1 chemotherapy on 10 th July 2018 she lost to follow up. 
Discussion
In 1771, Maximillian de Stoll described the first case of a primary carcinoma of the gallbladder [3] . This cancer is characterised by local and vascular invasion, extensive regional lymph node metastasis and distant metastasis. Metastases occur most frequently to the liver (76-86%), while regional lymph nodes are involved in about 60% of the cases. Metastases from gallbladder cancer occur to practically every organ including liver, lymph nodes, adrenal, kidney, spleen, brain, breast, thyroid, heart and uterus, those to the skeletal system are least frequent [4] . The incidence of bony metastasis is very rare and occurs only in the late stages of the disease, hence screening for bone metastasis is not routinely included in the workup of patients with carcinoma gallbladder. To our knowledge there are only 15 case reports of gallbladder carcinoma with skeletal metastasis in the English literature [ According to yochum and rowe [18] among cases of skeletal metastases from the carcinoma of the gall bladder, 90% are purely osteolytic and 10% are mixed lytic and blastic type with purely osteoblastic lesions being unknown. In our first patient, there were multiple mixed lytic-sclerotic skeletal lesions but in second case, lytic destructive lesion in distal 3 rd of right humerus was present. The management of patient with multifocal metastases is challenging. The role of chemotherapy in advanced disease is palliative without any significant survival benefit [19] . The primary aim of treatment in patients with metastatic disease is palliation of symptoms to help such patients live a quality life and let them die peacefully rather than agony from the advanced disease. In present both cases, bony metastases are treated by palliative radiotherapy. Due to poor general condition of my first patient, single agent weekly gemcitabine started but the patient after taking 1 st cycle chemotherapy lost to follow-up but the second patient having good health started on Gemcitabine + Cistplatin based chemotherapy and doing well. It will be interesting to see how this patient behaves in due course of time. However, the prognosis in these cases is unpredictable as very few cases have been reported.
Conclusion
Although rare, an occult gallbladder carcinoma may present with pathological fracture and/or severe bony pain due to metastasis. Early detection and prompt treatment would lead to better prognosis and improve the outcome.
